Research Article

维生素D缺乏与纤维囊性乳腺疾病之间的关系

卷 24, 期 7, 2024

发表于: 16 August, 2023

页: [899 - 905] 页: 7

弟呕挨: 10.2174/1566524023666230623155659

价格: $65

摘要

背景:维生素D缺乏在包括乳腺癌在内的多种人类癌症中的作用已得到证实,但它在良性乳腺疾病中的作用尚不清楚。本研究旨在确定纤维囊性乳腺(FB)疾病患者维生素D缺乏症的患病率。 方法:首先,通过横断面研究确定了纤维囊性乳腺的医院患病率。然后,采用病例对照法将患者分为两组;通过乳房疼痛、体格检查和超声检查确认为纤维性囊性乳房的女性被纳入病例组(N=48),年龄匹配的无纤维性囊性乳房的女性也被纳入对照组(N=48)。在记录了人口统计学和妇科特征、日晒情况、妇科记录和纤维囊性乳腺家族史后,采集血样测定维生素d。数据通过Stata软件分析。 结果:结果显示,各研究组在体重、乳房疼痛、乳房疼痛严重程度、乳房重量、纤维囊性乳房家族史、乳房疾病史、咖啡因摄入、日照情况等方面存在显著差异(p <0.05),但在年龄、职业、教育程度、妇科病史、糖尿病、高血压、肥胖、甲状腺功能减退、蔬菜、快餐、乳制品摄入等方面无显著差异。病例组维生素D缺乏发生率为45.8%,对照组为20.8%,差异有统计学意义(p <0.05)。 结论:维生素D缺乏在患有纤维囊性乳腺疾病的女性中更为常见,并可能在疾病的发展中发挥作用。

关键词: 乳腺纤维囊性疾病,维生素D缺乏,乳房疼痛,咖啡因,饮食,纤维囊性病变。

[1]
Taklif M, Hassan Pour A. The prevalence of fibrocystic changes in mammoplasty specimen referred to hazrat fatemeh hospital from 1994 to 2002. Majallah-i Ulum-i Pizishki-i Razi 2004; 10(38): 829-33.
[2]
Norwood SL. Fibrocystic breast disease. An update and review. J Obstet Gynecol Neonatal Nurs 1990; 19(2): 116-21.
[http://dx.doi.org/10.1111/j.1552-6909.1990.tb01629.x] [PMID: 2181087]
[3]
Stachs A, Stubert J, Reimer T, Hartmann S. Benign breast disease in women. Dtsch Arztebl Int 2019; 116(33-34): 565-74.
[PMID: 31554551]
[4]
Arulkumaran S. Essentials of gynecology. LWW Wolters Kluwer 2005; p. 698.
[5]
Emans SJH, Laufer MR, Goldstein DP. Emans, Laufer, Goldstein’s Pediatric and Adolescent Gynecology. Pennsylvania, United States: Wolters Kluwer Health 2005.
[6]
Alikhassi A, Comparing BI-RADS. With the 2003 edition: has it worked better? Arch Breast Cancer 2013; 2019: 51-4.
[7]
Malherbe K, Khan M, Fatima S. Fibrocystic breast disease. StatPearls 2019.
[8]
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.
[http://dx.doi.org/10.1056/NEJMra070553] [PMID: 17634462]
[9]
Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 2016; 103(4): 1033-44.
[http://dx.doi.org/10.3945/ajcn.115.120873] [PMID: 26864360]
[10]
Heshmat R, et al. Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iran J Public Health 2008; 37(1): 72-8.
[11]
Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys 2012; 523(1): 123-33.
[http://dx.doi.org/10.1016/j.abb.2012.04.001] [PMID: 22503810]
[12]
Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama JV. Association of vitamin D3 level with breast cancer risk and prognosis in African-American and Hispanic women. Cancers 2017; 9(12): 144.
[http://dx.doi.org/10.3390/cancers9100144] [PMID: 29064397]
[13]
Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Vitamin D and cancer. Anticancer Res 2006; 26(4A): 2515-24.
[PMID: 16886659]
[14]
Alipour S, Hadji M, Hosseini L, et al. Levels of serum 25-hydroxy-vitamin d in benign and malignant breast masses. Asian Pac J Cancer Prev 2014; 15(1): 129-32.
[http://dx.doi.org/10.7314/APJCP.2014.15.1.129] [PMID: 24528013]
[15]
O’Brien S, Kowdley GC. Benign breast diseases and body mass index: is there a correlation? Am Surg 2014; 80(5): 461-5.
[http://dx.doi.org/10.1177/000313481408000516] [PMID: 24887724]
[16]
Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992; 135(2): 130-41.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a116266] [PMID: 1536131]
[17]
Chen YY, Fang WH, Wang CC, et al. Examining the associations among fibrocystic breast change, total lean mass, and percent body fat. Sci Rep 2018; 8(1): 9180.
[http://dx.doi.org/10.1038/s41598-018-27546-3] [PMID: 29907750]
[18]
Bhettani MK, Rehman M, Altaf HN, et al. Correlation between body mass index and fibroadenoma. Cureus 2019; 11(7): e5219.
[http://dx.doi.org/10.7759/cureus.5219] [PMID: 31565622]
[19]
Maskarinec G, Jacobs S, Park SY, et al. Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 2017; 26(6): 854-61.
[http://dx.doi.org/10.1158/1055-9965.EPI-16-0789] [PMID: 28087607]
[20]
Kang C, LeRoith D, Gallagher EJ. Diabetes, obesity, and breast cancer. Endocrinology 2018; 159(11): 3801-12.
[http://dx.doi.org/10.1210/en.2018-00574] [PMID: 30215698]
[21]
Talaei A, Moradi A, Rafiei F. The evaluation of the effect of metformin on breast fibrocystic disease. Breast Dis 2017; 37(2): 49-53.
[http://dx.doi.org/10.3233/BD-160256] [PMID: 28598826]
[22]
Vakil DV, Elinson L, Morgan RW. Cystic disease, family history of breast cancer, and use of oral contraceptives. Cancer Detect Prev 1981; 4(1-4): 511-5.
[PMID: 7349817]
[23]
Coriaty Nelson Z, Ray RM, Gao DL, Thomas DB. Risk factors for fibroadenoma in a cohort of female textile workers in Shanghai, China. Am J Epidemiol 2002; 156(7): 599-605.
[http://dx.doi.org/10.1093/aje/kwf094] [PMID: 12244028]
[24]
Wu C, Ray RM, Lin MG, et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol 2004; 160(10): 945-60.
[http://dx.doi.org/10.1093/aje/kwh318] [PMID: 15522851]
[25]
Yousif ZH, Yacoub SE. Patterns of breast diseases among women attending breast diseases diagnosing center in erbil city/Iraq. Glob J Health Sci 2018; 10(4): 114-4.
[http://dx.doi.org/10.5539/gjhs.v10n4p114]
[26]
Zangana A, Garota S. Risk factors of breast cancer in a sample of Kurdish women of Kurdistan region - Iraq: A comparative study between pre-menopausal and post-menopausal women. Zanco J Med Sci 2012; 16(3): 262-7.
[http://dx.doi.org/10.15218/zjms.2012.0044]
[27]
Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 1997; 19(2): 310-27.
[http://dx.doi.org/10.1093/oxfordjournals.epirev.a017960] [PMID: 9494790]
[28]
Hunter DJ. Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med 1996; 334(6): 356-61.
[29]
Rohan TE, Negassa A, Caan B, et al. Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila) 2008; 1(4): 275-84.
[http://dx.doi.org/10.1158/1940-6207.CAPR-08-0003] [PMID: 19138971]
[30]
Boyle CA, Berkowitz GS, LiVolsi VA, et al. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. J Natl Cancer Inst 1984; 72(5): 1015-9.
[PMID: 6585579]
[31]
Su X, Colditz GA, Collins LC, et al. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat 2012; 134(2): 783-91.
[http://dx.doi.org/10.1007/s10549-012-2091-8] [PMID: 22622809]
[32]
Baer HJ, Schnitt SJ, Connolly JL, et al. Adolescent diet and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev 2003; 12(11 Pt 1): 1159-67.
[PMID: 14652275]
[33]
Hislop TG, Band PR, Deschamps M, et al. Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 1990; 131(2): 263-70.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a115496] [PMID: 2296979]
[34]
Boeke CE, Tamimi RM, Berkey CS, et al. Adolescent dietary vitamin D and sun exposure in relation to benign breast disease. Cancer Causes Control 2015; 26(8): 1181-7.
[http://dx.doi.org/10.1007/s10552-015-0612-6] [PMID: 26084210]
[35]
Lopes N, Paredes J, Costa JL, Ylstra B, Schmitt F. Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Res 2012; 14(3): 211.
[http://dx.doi.org/10.1186/bcr3178] [PMID: 22676419]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy